About Salient Surgical Technologies
Salient Surgical Technologies is a company based in Portsmouth (United States) founded in 1999 was acquired by Medtronic in July 2011. Salient Surgical Technologies has raised $120.5 million across 7 funding rounds from investors including Medtronic, Legacy Health and BMO Global Asset Management. Salient Surgical Technologies operates in a competitive market with competitors including Sequana Medical, Yaqrit, CalmiGo, Xlumena and Autem Therapeutics, among others.
- Headquarter Portsmouth, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Salient Surgical Technologies Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Salient Surgical Technologies
Salient Surgical Technologies has successfully raised a total of $120.5M across 7 strategic funding rounds. The most recent funding activity was a Series G round of $15.1 million completed in January 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Salient Surgical Technologies
Salient Surgical Technologies has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Legacy Health and BMO Global Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Expansion stage tech-focused VC firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for Salient Surgical Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Salient Surgical Technologies
Investment portfolio details for Salient Surgical Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Salient Surgical Technologies
Detailed financials for Salient Surgical Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Salient Surgical Technologies Comparisons
Peer comparison for Salient Surgical Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Salient Surgical Technologies
Salient Surgical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Yaqrit, CalmiGo, Xlumena and Autem Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Liver dialysis devices for treating cirrhosis and failure are developed.
|
|
| Locked | Locked | Locked |
Stress-relief devices are developed using smart breathing regulation technology.
|
|
| Locked | Locked | Locked |
Image-guided therapeutic endoscopy devices are developed for medical procedures.
|
|
| Locked | Locked | Locked |
Bioelectric platforms for cancer treatment are developed.
|
Detailed competitors of Salient Surgical Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Salient Surgical Technologies
Complete news archive for Salient Surgical Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salient Surgical Technologies
Salient Surgical Technologies was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Salient Surgical Technologies is headquartered in Portsmouth, United States. It is registered at Portsmouth, Virginia, United States.
Geoffery Martha is the current CEO of Salient Surgical Technologies.
Salient Surgical Technologies is a funded company, having raised a total of $120.5M across 7 funding rounds to date.
Founded in 1999 in Portsmouth, United States, electrosurgical systems for medical applications were developed by Salient Surgical Technologies. Initial focus was placed on monopolar devices used in liver and pancreatic resections. Subsequent products included the bipolar AQUAMANTYS System, applied in orthopaedic reconstruction, spine surgery, trauma, and oncology. Acquisition by Medtronic occurred in 2011, integrating these technologies into broader surgical solutions.
Salient Surgical Technologies's top competitors include Sequana Medical, Yaqrit and CalmiGo.
Salient Surgical Technologies has 18 investors. Key investors include Medtronic, Legacy Health, BMO Global Asset Management, Piper Jaffray, and Brait.